Flexion Therapeutics
FLXN
#7639
Rank
C$0.65 B
Marketcap
C$13.09
Share price
0.00%
Change (1 day)
8,408.30%
Change (1 year)

Earnings for Flexion Therapeutics (FLXN)

Earnings in 2021 (TTM): -C$0.11 Billion

According to Flexion Therapeutics 's latest financial reports the company's current earnings are C$0.10 Billion. In 2020 the company made an earning of -C$0.14 Billion, an increase over its 2019 earnings that were of -C$0.2 Billion.

Earnings history for Flexion Therapeutics from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-C$0.11 Billion-25.21%
2020-C$0.14 Billion-29.78%
2019-C$0.2 Billion-13.8%
2018-C$0.23 Billion21.98%
2017-C$0.19 Billion79.92%
2016-C$0.11 Billion53.34%
2015-C$65.66 Million69.98%
2014-C$38.63 Million51.72%
2013-C$25.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$26.86 B-23,681.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$10.00 B-8,877.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
C$5.4 M-104.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
C$25.32 M-122.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-C$14.77 Million-87.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ampio Pharmaceuticals
AMPE
-C$12.39 Million-89.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
-C$90.12 Million-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA